NONTUBERCULOUS MYCOBACTERIUM INFECTION
Clinical trials for NONTUBERCULOUS MYCOBACTERIUM INFECTION explained in plain language.
Never miss a new study
Get alerted when new NONTUBERCULOUS MYCOBACTERIUM INFECTION trials appear
Sign up with your email to follow new studies for NONTUBERCULOUS MYCOBACTERIUM INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug candidate takes on stubborn lung infection
Disease control CompletedThis study tests whether adding delpazolid to standard treatment can reduce bacterial levels in people with hard-to-treat Mycobacterium abscessus lung infections. Participants take delpazolid tablets daily for 12 weeks, with the option to continue up to one year if there is clini…
Matched conditions: NONTUBERCULOUS MYCOBACTERIUM INFECTION
Phase: PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could fewer antibiotics be better for MAC lung disease?
Disease control CompletedThis study tested whether taking two antibiotics instead of three is just as effective for treating a lung infection called MAC, while causing fewer side effects. 474 adults with MAC lung disease were randomly assigned to receive either two or three drugs for 12 months. The goal …
Matched conditions: NONTUBERCULOUS MYCOBACTERIUM INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC